Dr. Yaser Homsi, MD

Dr. Homsi practices at Hoag Cancer Center Irvine - HOPD in Irvine, California.

Dr. Homsi's NPI, 1790943983, was assigned on May 25, 2008. Dr. Homsi graduated from University of Aleppo Faculty of Medicine in 2003. Dr. Homsi holds California license C145827.

Dr. Homsi's primary practice is Hoag Cancer Center Irvine - HOPD, at 16105 Sand Canyon Ave, Irvine, CA 92618.

Dr. Homsi's primary practice is Hoag Cancer Center Irvine - HOPD in Irvine, California. Dr. Homsi is also affiliated with UCI Health - Orange. The medical group on file is Hoag Clinic. Dmand AI also links Dr. Homsi to 1 more hospital, 1 home health agency and 1 other site, each named with a free account. Dr. Homsi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Homsi practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Homsi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Homsi is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Homsi's licenses on file in 3 states: California, West Virginia and Indiana.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances, immune deficiency disease and lung cancer among the conditions Dr. Homsi treats.

CMS data shows 1,127 Medicare services from Dr. Homsi across 11 procedure codes in 2024, for 317 Medicare patients. Medicare paid $103,151 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 317 Medicare patients who saw Dr. Homsi in 2024. The largest group is 75 to 84, with 127 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Homsi's median patient age at 75, with 56% women.

In 2024, Dr. Homsi wrote 1,420 Medicare Part D claims for 231 patients. 81% of them were for generic drugs. CMS names the drug for 1,053 of them, across 32 drugs with 11 or more claims each, at $1,478,087 in total drug cost. In 2023, CMS named 685 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Homsi for performance year 2024, reported as part of a group. Dr. Homsi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Homsi as offering telehealth.

Dmand AI links Dr. Homsi to 1 clinical trial. Conditions studied include Oral Ulcer and Stomatitis.

CMS Open Payments shows 409 general payments to Dr. Homsi from 61 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Daiichi Sankyo Inc. paid the most, $1,549.

Dmand AI lists 1 award for Dr. Homsi, most recently CMS Stage 1 EHR in 2014.

Dr. Homsi graduated from University of Aleppo Faculty of Medicine in 2003. Dr. Homsi is a member of ASCO and ASH.

Dr. Homsi is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.